Indirect treatment comparisons find enhanced effectiveness of pegcetacoplan versus crovalimab in both complement inhibitor-naïve and -experienced patients with paroxysmal nocturnal hemoglobinuria. [PDF]
J Comp Eff ResMing Wong RS +6 more
europepmc +1 more source
Causes and outcomes of pediatric thrombotic microangiopathy. [PDF]
Res Pract Thromb HaemostScully M.
europepmc +1 more source
Therapeutic advances in eculizumab for atypical hemolytic uremic syndrome: a narrative review. [PDF]
Front PharmacolZhang D, Xiao Y, Ma H.
europepmc +1 more source
Real-world efficacy of eculizumab in generalized myasthenia gravis patients with poor early response to efgartigimod: a prospective cohort study. [PDF]
Front ImmunolAn X +5 more
europepmc +1 more source
Thrombotic Events in Patients With Paroxysmal Nocturnal Haemoglobinuria Using Eculizumab: A Post-Marketing Surveillance Sub-Analysis. [PDF]
EJHaemIkezoe T +4 more
europepmc +1 more source
Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China. [PDF]
Neurol TherLi Y +8 more
europepmc +1 more source
Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review. [PDF]
Front ImmunolLi YX, Hao YL.
europepmc +1 more source
Case Report: Atypical hemolytic uremic syndrome triggered by Rhinovirus/Enterovirus infection with cutaneous thrombotic microangiopathy requiring surgical management. [PDF]
Front PediatrShen J +5 more
europepmc +1 more source
A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab. [PDF]
Clin Kidney JGopireddy NSR +4 more
europepmc +1 more source